Search results
Nestlé taps into weight loss drug market with new frozen food line for Ozempic users
Salon.com· 17 hours agoMajor corporations are tapping into the lucrative weight loss drug market, which is anticipated to...
Axios Vitals
Axios· 3 days agoThe blockbuster success of new anti-obesity drugs helped boost the corporate reputations of pharmaceutical brands, according to new rankings from the annual Axios/Harris Poll 100. Why it matters ...
Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
The Wall Street Journal· 1 day agoThe outlay to expand an Indiana production site, combined with a previous $3.7 billion commitment,...
More Weight Loss With Anti-Obesity Meds and Hormone Therapy?
Medscape· 3 days ago"To date, there are no studies comparing weight loss outcomes to any of the anti-obesity...
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 20 hours agoNovo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 active...
Eli Lilly to invest $5.3 billion to expand production of Zepbound and Mounjaro By Investing.com
Investing.com· 2 days agoEli Lilly (NYSE:LLY) is making a $5.3 billion investment to expand manufacturing for its high-demand...
Nestlé introduced a new frozen food brand aimed at weight-loss drug users
Axios· 4 days agoNestlé on Tuesday announced a new frozen food brand aimed at weight-loss drug users in one of the...
Nestlé to debut Vital Pursuit healthy food brand for Ozempic, Wegovy medication users
USA TODAY via Yahoo News· 4 days agoNestlé is launching a new food line next year meant to support Americans who use weight-management...
AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters
Investing.com· 5 days agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier...
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 Years and Support Heart Health
Verywell Health via Yahoo News· 4 days ago“This finding shifts our understanding, emphasizing semaglutide’s potential as a cardiovascular...
